I have no problem with bringing in an investment banker at that time when Medizone reaches a certain amount of cash flow and the financial stability is more on solid ground. I feel that Ed would be more open to that suggestion as well. I feel that there are much better use of the limited resources that the company has right now. Besides, I would think that the market research in terms of sales projection and asset valuation would be more accurate once the company gets on the ground running with a few orders down the road. Also, the market research being paid by the F500 acquirer remains a possibility as they would be interested in knowing the different market potential as well.